癌症中的翻译失调是可向抗原的来源
Chen Weller1, Osnat Bartok1, Christopher S McGinnis2
1Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot 7610001, Israel.
Cancer cell
|March 28, 2025
概括
通过删除瘤细胞中的TYW2基因来破坏翻译忠实性,产生异常,增强抗瘤免疫力. 这一发现表明,针对翻译忠实性缺陷的向可以提高癌症免疫治疗的有效性.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 分子生物学分子生物学
背景情况:
- 由MHC分子呈现的异常可以触发T细胞对瘤的反应.
- 癌细胞往往表现出蛋白质合成的失调,可能导致免疫性异常.
- 准这些异常为基于T细胞的癌症治疗提供了一个潜在的策略.
研究的目的:
- 研究转化失调在控制瘤中的作用.
- 探索如何破坏翻译忠实性影响瘤免疫性和治疗反应.
主要方法:
- 在瘤细胞中删除tRNA wybutosine (yW) 合成蛋白2 (TYW2) 以诱导翻译错误.
- 分析下游对翻译真实性和免疫性的影响,使用免疫学,基因组学和功能性测试.
- 在体内研究评估瘤生长和对抗编程细胞死亡1 (PD-1) 检查点阻塞的反应.
主要成果:
- TYW2淘汰赛 (KO) 瘤细胞产生了免疫原外.
- 失去TYW2显著增加了瘤免疫性.
- 在体内,TYW2缺陷使瘤对抗PD-1检查点阻塞疗法的敏感.
- 在人类癌症患者中,TYW2表达的减少与对检查点封锁的更好反应相关.
结论:
- 翻译忠实度的缺陷,特别是通过TYW2损失,可以驱动瘤免疫性.
- 准转化忠实性代表了增强癌症免疫治疗的新策略.
- 利用TYW2介导的翻译错误可以提高检查点阻塞疗法的有效性.
相关概念视频
Mitogens and the Cell Cycle
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Metastasis
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...


